Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral ESPB for Postoperative Pain in Pediatric Cardiac Surgery
NCT05142176Unknown
- Sponsor
- Tanta University
- Start
- Feb 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoint: Modified Objective Pain Score at 12 hours. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05142176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05142176.